Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

Panobinostat and other HDAC inhibitors in relapsed Multiple Myeloma

Editor By No Comments1 Min Read

Morie A. Gertz, MD of Mayo Clinic discusses Panobinostat and other HDAC inhibitors in relapsed Multiple Myeloma at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.

Share.

Related Posts